PositiveID Corporation (PSID)
-OTC BB 0.32
0.03(10.34%) 3:45PM EDT
| Prev Close: | 0.29 |
|---|
| Open: | 0.27 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 0.50 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.27 - 0.33 |
|---|
| 52wk Range: | 0.25 - 1.50 |
|---|
| Volume: | 128,121 |
|---|
| Avg Vol (3m): | 107,546 |
|---|
| Market Cap: | N/A |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- PositiveID requests withdrawal of registration statementat theflyonthewall.com(Fri 4:05PM EDT)
- POSITIVEID CORP FinancialsEDGAR Online Financials(Thu, May 23)
- POSITIVEID CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 20)
- PositiveID files to sell 4.5M shares of ommon stocktheflyonthewall.com(Mon, May 13)
- William J. Caragol, Chairman and CEO of PositiveID, is Featured in a New Audio Interview at SmallCapVoice.comPR Newswire(Wed, May 1)
- Hanoverfinancialservices.com Issues Research and News Update on PositiveID CorporationMarketwired(Mon, Apr 29)
- Photo Release -- PositiveID Corporation Launches Development of Firefly Dx to Confirm Biological Threats in the Field Within MinutesGlobeNewswire(Mon, Apr 29)
- POSITIVEID CORP FinancialsEDGAR Online Financials(Fri, Apr 26)
- PositiveID Corporation Announces Reverse Stock SplitGlobeNewswire(Mon, Apr 22)
- POSITIVEID CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of MaEDGAR Online(Mon, Apr 22)
- POSITIVEID CORP Files SEC form 10-K, Annual ReportEDGAR Online(Tue, Apr 16)
- PositiveID Corporation Publishes Report on Market Opportunities for M-BAND and DragonflyGlobeNewswire(Mon, Mar 25)
- POSITIVEID CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Mon, Mar 25)
- POSITIVEID CORP Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Fri, Mar 22)
- PositiveID Corporation Reviews 2012 Highlights and 2013 OutlookGlobeNewswire(Tue, Mar 12)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-12)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
PositiveID Corporation develops medical devices and biological detection systems focusing primarily on diabetes management, rapid medical testing, and airborne bio-threat detection.
View More